Alcoa Board Approves Quarterly Dividends
Get Alerts AA Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.6%
EPS Growth %: +448.7%
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Alcoa (NYSE: AA) today declared (a) a quarterly common stock dividend of 3 cents per share payable May 25, 2016 to holders of record of the common stock at the close of business on May 6, 2016; and (b) a dividend of 93.75 cents per share on Alcoa’s $3.75 cumulative preferred stock (“Class A Stock”) payable July 1, 2016 to holders of record of the Class A Stock at the close of business on June 10, 2016.
About Alcoa
A global leader in lightweight metals technology, engineering and manufacturing, Alcoa innovates multi-material solutions that advance our world. Our technologies enhance transportation, from automotive and commercial transport to air and space travel, and improve industrial and consumer electronics products. We enable smart buildings, sustainable food and beverage packaging, high performance defense vehicles across air, land and sea, deeper oil and gas drilling and more efficient power generation. We pioneered the aluminum industry over 125 years ago, and today, our approximately 60,000 people in 30 countries deliver value-add products made of titanium, nickel and aluminum, and produce best-in-class bauxite, alumina and primary aluminum products. For more information, visit www.alcoa.com, follow @Alcoa on Twitter at www.twitter.com/Alcoa and follow us on Facebook at www.facebook.com/Alcoa.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160329006479/en/
Alcoa
Investors
Matthew Garth, 212-836-2714
[email protected]
or
Media
Monica
Orbe, 212-836-2632
[email protected]
Source: Alcoa
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alcoa (AA) call put ratio 4.2 calls to 1 puts as share price up 2.7%
- FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Ce
- TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Twitter, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share